重要提醒:2025.12.15 12:00-12:50期间发布的求助,下载出现了问题,现在已经修复完毕,请重新下载即可。如非文件错误,请不要进行驳回。

ROS -mediated anticancer response of potent copper(II) drug entities derived from S, O and N, N chelating donor scaffold: Single X-ray crystal diffraction and spectroscopic studies

化学 单斜晶系 结晶学 细胞毒性 三斜晶系 单晶 螯合作用 氧化还原 晶体结构 立体化学 体外 无机化学 生物化学 有机化学
作者
Shariq Yousuf,Farukh Arjmand,Sartaj Tabassum
出处
期刊:Journal of Molecular Structure [Elsevier]
卷期号:1262: 132989-132989 被引量:3
标识
DOI:10.1016/j.molstruc.2022.132989
摘要

• The structure of complexes 1 and 2 were thoroughly characterized. • The complexes 1 and 2 were synthesized with an idea of attaining a quick biologically Cu(II)/Cu(I) redox cycle. • The high in vitro cytotoxicity exhibited by five coordinated Cu(II) complex. • Mode of binding of 1 and 2 towards ct-DNA was studied. New Cu(II) anticancer drug entities derived from S, O, and N, N donor chelating scaffolds were synthesized and thoroughly characterized by various spectroscopic and single X-ray diffraction studies. The single X-ray crystal structure of 1 and 2 revealed a monoclinic and triclinic crystal system with space group C 2 / c and P -1, respectively. The biomolecular interaction studies of 1 and 2 with ct-DNA were carried out by employing a battery of biophysical techniques, viz., absorption, emission, circular dichroic, and electrochemical (CV) and corroborative results of these experiments demonstrated avid electrostatic binding via surface groove. The synthesized Cu(II) complexes showed high efficacy as ROS generators involving Cu(II)/Cu(I) redox-active pair as evidenced by cleavage assay in the presence of radical scavengers. The ROS generation in the presence of copper-based complexes is considered one of the most favorable cell death mechanisms for the inhibition of cancers. In vitro anticancer activity of 1 and 2 was, therefore, evaluated against a panel of five human cancer cell lines, namely MCF-7, MDA-MB-231, Hop-62, AW1356, and SiHa, and results of cytotoxicity demonstrated good anticancer response against all tested cancerous strains with GI 50 value <10 µM, except by 1 against MDA-MB-231, Hop-62 and AW1356 cell lines. Interestingly, 2 has displayed considerable cytotoxicity against MCF-7, Hop-62, and SiHa cancer cell lines even better than that of standard drug adriamycin. Furthermore, computational DFT studies validated the high binding efficacy and significant cytotoxicity of complex 2, which could be attributed to high positive charge density over the Cu(II) center. ROS induced DNA damage resulted Cell Death.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bbzzzha发布了新的文献求助10
刚刚
刚刚
刚刚
1秒前
陶醉的纲完成签到,获得积分10
1秒前
着急的向雁完成签到,获得积分10
1秒前
xxy应助nebula采纳,获得30
1秒前
阳光桐完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
喜洋羊完成签到,获得积分20
2秒前
淀粉肠发布了新的文献求助20
3秒前
3秒前
zeng5288发布了新的文献求助30
3秒前
3秒前
hehexi发布了新的文献求助10
4秒前
111发布了新的文献求助100
4秒前
无问西东完成签到,获得积分10
4秒前
wwww完成签到,获得积分10
5秒前
5秒前
量子星尘发布了新的文献求助10
6秒前
憨厚波涛发布了新的文献求助30
6秒前
rock发布了新的文献求助200
6秒前
天玄发布了新的文献求助10
6秒前
迷你的唇彩完成签到,获得积分20
6秒前
7秒前
小三子完成签到,获得积分10
7秒前
幽默尔蓝发布了新的文献求助10
8秒前
8秒前
8秒前
俊逸翠柏完成签到,获得积分10
9秒前
9秒前
理li完成签到,获得积分10
10秒前
10秒前
我好樊完成签到,获得积分10
10秒前
蛋卷完成签到,获得积分10
11秒前
斯文败类应助cup采纳,获得10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Haematolymphoid Tumours (Part A and Part B, WHO Classification of Tumours, 5th Edition, Volume 11) 400
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
Unraveling the Causalities of Genetic Variations - Recent Advances in Cytogenetics 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5466271
求助须知:如何正确求助?哪些是违规求助? 4570197
关于积分的说明 14323735
捐赠科研通 4496698
什么是DOI,文献DOI怎么找? 2463500
邀请新用户注册赠送积分活动 1452381
关于科研通互助平台的介绍 1427516